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Abstract: We aimed to assess the effects of bradykinin (BK) on the proliferation, apoptosis, and cycle of glomerular mesangial cells
via the transforming growth factor-β 1 (TGF-β1)/Smad signaling pathway. Rat glomerular mesangial cells, HBZY-1, were divided into
normal group (untreated), model group (5 ng/L TGF-β1), BK group (5 ng/L TGF-β1 + 1 ng/L BK), and inhibitor group [5 ng/L TGF-β1
+ 1 ng/L LY2109761 (TGF-β1-specific inhibitor)]. The cell proliferation, cycle, apoptosis, expression of type I collagen (Col-1), and
protein expressions of Col-1, TGF-β1, and phosphorylated Smad2 (p-Smad2) were detected by EdU labeling, flow cytometry, acridine
orange/ethidium bromide (AO/EB) dual staining, immunofluorescence assay, and Western blotting, respectively. Compared with the
normal group, the cell proliferation rate (P = 0.02) and protein expression levels of Col-1 (P = 0.02), TGF-β1 (P = 0.01), p-Smad2
(P = 0.02), and p-Smad7 (P = 0.00) in the model group significantly increased, and apoptosis rate (P = 0.01) significantly decreased.
Compared with the model group, the BK and inhibitor groups significantly decreased in proliferation rate (P = 0.01) and protein
expression levels of Col-1 (P = 0.01), TGF-β1 (P = 0.01), and p-Smad2 (P = 0.00). Also, they were significantly elevated in apoptosis rate
(P = 0.02) and p-Smad7 protein expression (P = 0.02). BK regulates the proliferation, apoptosis, and the cycle of glomerular mesangial
cells by inhibiting the TGF-β1/Smad signaling pathway.
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1. Introduction
Glomerular mesangial cells are primary effector cells for
the progression of chronic progressive kidney diseases
into renal fibrosis (Lee et al., 2018). Mesangial cells are
activated by multiple factors-triggered inflammatory
cytokines to cause hyperproliferation, which enlarges
the kidney mesangial area and decreases the glomerular
filtration rate, thus forming a pathological state of
sclerosis (Nguyen et al., 2019). Therefore, suppressing
the abnormal proliferation of glomerular mesangial cells
is crucial for the treatment of chronic kidney disease
and chronic renal insufficiency, as well as the prevention
and treatment of renal fibrosis. Bradykinin (BK) is an
inflammatory mediator. Liu et al. (2018) found an increase
in BK expression on the surface of glomerular mesangial
cells in rats with chronic kidney disease. BK obviously
affects glomerulosclerosis, but the mechanism remains
unclear (Qin et al., 2019). Transforming growth factor-β

1 (TGF-β1) is the primary mediator of glomerulosclerosis
leading to renal interstitial fibrosis (Song et al., 2017). As a
strong fibrogenic factor, TGF-β1 has increased expression
in the case of chronic glomerulitis (Pereira et al., 2010).
Besides, it transfers extracellular signals into the nucleus
based on proteins of the Smad family to cooperate with
the expressions of related genes, which directly promotes
the synthesis of type I collagen (Col-1) and the progression
of glomerular fibrosis. Sen et al. (2019) confirmed that
suppressing the TGF-β1 signaling pathway remarkably
mitigated renal fibrosis induced by chronic renal
insufficiency. In addition, Catalán et al. (2019) verified that
BK resisted the fibrosis of rat cardiomyocytes by evidently
inhibiting TGF-β1 signal. However, the roles of BK and
TGF-β1 in kidneys have not been reported until now. In
this study, rat glomerular mesangial cells were cultured in
vitro to investigate the antifibrotic mechanism of BK based
on TGF-β1/Smad signals, aiming to provide theoretical
support for clinical practice.
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2. Materials and methods
2.1. Cells, reagents, and apparatus
Rat glomerular mesangial cell line HBZY-1 was provided
by the Cell Bank of Chinese Academy of Sciences
(China). Fetal bovine serum (FBS), trypsin, and RPMI1640 medium were purchased from Gibco Laboratories
(Gaithersburg, MD, USA). Rabbit antihuman Col-1,
TGF-β1, phosphorylated Smad2 (p-Smad2), and p-Smad7
antibodies and horseradish peroxidase (HRP) were
bought from Abcam Inc. (Cambridge, MA, USA). EdU kit,
bicinchoninic acid (BCA) protein concentration detection
kit, acridine orange/ethidium bromide (AO/EB) staining
kit, and Western blotting kit were purchased from SigmaAldrich Corp. (St. Louis, MO, USA). TGF-β1-specific
inhibitor LY2109761 was provided by Nanjing Jiancheng
Bioengineering Institute (China). The main apparatus
included a CO2 cell incubator (Beckman Coulter, Inc.,
Brea, CA, USA), MK3 microplate reader (Shimadzu
Corporation, Kyoto, Japan), a flow cytometer (Shel Lab;
Sheldon Manufacturing, Inc., Cornelius, OR, USA),
LIOOS600T fluorescence microscope (Nikon Corp.,
Tokyo, Japan), and a high-speed refrigerated centrifuge
(Beijing Liuyi Biotechnology Co., Ltd., Beijing, China).
2.2. Cell culture and experimental grouping
HBZY-1 cells were centrifuged after the addition of
RPIM-1640 medium containing 20% FBS to remove
supernatant. Afterwards, the cells were suspended using
culture medium, inoculated in a culture bottle with 5%
CO2 at 37 °C and digested with 0.25% trypsin when the cell
density reached 85%, followed by subculture in complete
medium. Then, the cells in the logarithmic growth phase
were assigned into normal group (untreated), TGF-β1
stimulation group (model group, 5 ng/L TGF-β1), BK +
TGF-β1 stimulation group (BK group, 5 ng/L TGF-β1 +
1 ng/L BK), and TGF-β1-specific inhibitor LY2109761
stimulation group (inhibitor group, 5 ng/L TGF-β1 + 1
ng/L LY2109761).
2.3. Detection of cell proliferation by EdU labeling
The cells were inoculated into a 6-well culture plate at the
concentration of 5 × 105/well. Different groups of cells
were treated in the same way as indicated above, and the
concentration of EdU working solution was adjusted to 20
μmol/L. Then, 1 mL of EdU working solution was added
to the cell culture plate, mixed gently, and cultured in a
5% CO2 incubator at 37 °C for 2 h. After the supernatant
was discarded, the cells were fixed with 4% formaldehyde
for 30 min. After being washed by phosphate-buffered
saline (PBS) twice (5 min each time), the cells were left
still in PBS with 0.3% Triton X-100 for 20 min at constant
temperature. Subsequently, click reaction solution was
prepared according to the kit’s requirements, and 500 μL
of the reaction solution was added into each well with a
pipette for incubation at constant temperature for 20 min.
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Then, the cells were incubated in 1 mL of DAPI solution
for 30 min in the dark, washed with PBS, and observed
under the fluorescence microscope. Ultimately, images
were obtained to analyze the cell proliferation rate.
2.4. Detection of cell cycle by flow cytometry
The cells were treated in the same way as indicated above.
They were washed with precooled PBS, suspended with
300 μL of buffer, and inoculated in a 24-well plate at the
concentration of 1 × 106/mL. After being cultured in the
5% CO2 incubator at 37 °C for 24 h, 1 mL of PBS was
utilized to prepare a single cell suspension which was then
dripped into 5 mL of 75% ethanol at 4 °C and fixed at 4
°C overnight. Subsequently, centrifugation was conducted
at 1,000 r/min for 2 min to separate the liquid. The lower
layer of the suspension was obtained, washed with PBS 3
times, and prepared into a cell suspension, using 200 μL
of Annexin V-FITC binding solution. Then, 20 μL of PI
staining solution was added and shaken gently at 200 r/
min for 2 min, followed by placement in ice bath in the
dark for 45 min. Finally, cell cycle changes were detected
by the flow cytometer.
2.5. Detection of cell apoptosis by AO/EB dual staining
The cells were seeded into the 6-well culture plate at the
concentration of 5 × 105/well, and treated in the same way
as above. After being cultured in the 5% CO2 incubator at
37 °C for 24 h, the supernatant was discarded on the next
day, and the cells were rinsed by 20 mL of PBS 3 times
and prepared into a single cell suspension. Then, 60 μL
of freshly prepared AO/EB fluorescent staining solution
(equal volumes of 100 mg/L AO and 100 mg/L EB) and 2
mL of PBS were added. The resulting mixture was excited
at 388 nm under the fluorescence microscope, and cell
apoptosis was observed.
2.6. Detection of Col-1 expression by immunofluorescence assay
The cells were inoculated in a 6-well culture plate at the
concentration of 5 × 105/well and treated in the same way as
above. After being cultured in the 5% CO2 incubator at 37
°C for 24 h, the cells were fixed with 10% paraformaldehyde
and prepared into ultrathin frozen sections according to
the instructions of the immunofluorescence kit. Under the
fluorescence microscope, red fluorescence indicated an
expression of Col-1 (Weng et al., 2019).
2.7. Detection of Col-1, TGF-β1, p-Smad2, and p-Smad7
protein expressions by Western blot
The cells in different groups were treated in the same way as
above, seeded into the 24-well plate at the concentration of
1 × 104/well, and cultured in the 5% CO2 incubator at 37 °C
for 24 h. After the cells were collected, target proteins Col1, TGF-β1, p-Smad2, and p-Smad7 were extracted, and
their expressions were measured by BCA kit. Subsequently,
50 μg of proteins were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, after which the
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protein samples were transferred onto a polyvinylidene
fluoride membrane by wet transfer method. Then, the
membrane was blocked with 10% skimmed milk for 3 h
and incubated with primary antibodies (1:500 diluted) at
4 °C overnight. After being washed, the membrane was
incubated with HRP-labeled secondary antibodies (1:5000
diluted) for 3 h, followed by 30 min of color development
by using enhanced chemiluminescence reagent. After
image exposure, development and fixation, the protein
expression level was represented by using GAPDH as the
internal reference.
2.8. Statistical analysis
SPSS 16.0 software was employed for data analysis, and
GraphPad Prism 5.01 software was used for plotting.
Comparisons among multiple groups were conducted by
univariate analysis, and the t-test was applied for pairwise
comparisons. P < 0.05 indicated a statistically significant
difference.
3. Results
3.1. Cell proliferation capacities
The EdU labeling assay showed that compared with the
normal group, the proportion of EdU-positive HBZY1 cells and cell proliferation rate in the model group
increased significantly after TGF-β1 stimulation (P =
0.02). Compared with the model group, the proportion of
EdU-positive cells and cell proliferation rate in BK group
and inhibitor group decreased significantly (P = 0.01), but
the latter two groups had similar results (P = 0.09) (Figure
1).

Figure 1. Cell proliferation capacities detected by EdU labeling ( x
with model group, #P < 0.05.

3.2. Cell cycle distribution
Flow cytometry revealed that the cell cycle of the normal
group hardly changed. Compared to the normal group,
the percentage of cells in G1 phase decreased and that in
G2/S phase increased significantly in the model group (P
= 0.01), indicating increased protein synthesis and raised
proportion of cells in the division stage. Compared with
the model group, BK and inhibitor groups had significantly
elevated the percentage of cells in G1 phase and reduced
percentage in G2/S phase (P = 0.01), suggesting cell cycle
arrest in G1 phase (Table and Figure 2).
3.3. Cell apoptosis
AO can penetrate cells with intact cell membranes, enter
the nucleus, and bind DNAs on chromosomes to emit
bright green fluorescence. In contrast, EB can only pass
through cells with damaged cell membranes, enter the
nucleus, and bind DNAs on chromosomes to emit orange
fluorescence (Metz et al., 2019). AO/EB dual staining
(Figure 3) exhibited that a small number of cells in the
normal group showed orange fluorescence, while the
model group exhibited green fluorescence in the nucleus
without apoptosis. In addition, BK and inhibitor groups
displayed obvious lumpy orange fluorescence, indicating
that there was a large number of apoptotic cells.
3.4. Col-1 expressions in cells
Col-1 is the marker protein of renal cell fibrosis. In this
study, the changes in Col-1 expression were detected by
immunofluorescence assay. Compared with the normal
group, the expression of Col-1 in the model group
significantly increased after stimulation by TGF-β1 (P =

± s , n = 5). Compared with normal group, *P < 0.05; compared
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Table. Apoptotic rate and cell cycle
distribution ( x ± s , n = 5).
Group

G1 phase

G2/S phase

Normal

78.31 ± 0.22

17.48 ± 0.92

Model

55.08 ± 3.21*

42.61 ± 3.51*

BK

68.46 ± 1.02#

30.11 ± 2.82#

Inhibitor

66.95 ± 1.81#

31.05 ± 3.84#

Compared with normal group, *P < 0.05;
compared with model group, #P < 0.05.

0.02). Compared with the model group, the expressions in
BK and inhibitor groups declined significantly (P = 0.01),
but the latter two groups had similar expressions (P = 0.09)
(Figures 4 and 5).
3.5. TGF-β1, p-Smad2, and p-Smad7 protein expressions
in cells
The protein expressions of TGF-β1, p-Smad2, and
p-Smad7 in each group were detected by Western blotting.
Compared with the normal group, the protein expressions

of TGF-β1, p-Smad2, and p-Smad7 were significantly
elevated in the model group (P = 0.01, P = 0.02, P = 0.00).
The protein expressions of TGF-β1 and p-Smad2 in BK and
inhibitor groups dropped significantly (P = 0.01, P = 0.00),
while the protein expression of p-Smad7 rose significantly
(P = 0.02). There were no significant differences between
BK group and inhibitor group (P = 0.07) (Figure 6).
4. Discussion
Diabetic nephropathy (DN) is one of the common chronic
complications of diabetes mellitus, the main cause of endstage renal failure, and one of the main causes of death and
disability. Thus, it has seriously threatened the physical and
mental health and quality of life of diabetic patients (Zhu et
al., 2018). DN is typified by the thickening of the glomerular
basement membrane, the proliferation of mesangial cells,
the accumulation of extracellular matrix to block the
glomerular capillary lumen, and the loss of glomerular
filtration function (Wu et al., 2018). Hyperglycemia plays
a fundamental role in the onset and progression of DN,
so good controlling of blood glucose level can reverse
or relieve early diabetic kidney diseases. Additionally,

Figure 2. Cell cycle distribution detected by flow cytometry ( x
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± s , n = 5).
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Figure 3. Cell apoptosis detected by AO/EB dual staining ( x ± s , n = 5). A: Control group; B: model group; C: BK
group; D: inhibitor group. Compared with normal group, *P < 0.05; compared with model group, #P < 0.05.

Figure 4. Col-1 expressions in cells detected by immunofluorescence assay ( x
model group; C: BK group; D: inhibitor group.

reversing the proliferation state of glomerular mesangial
cells in a high glucose environment and the high secretion

± s , n = 5). A: Control group; B:

of extracellular matrix is a critical factor for the treatment
of DN. The most important active kinin is BK, which

21

DONG et al. / Turk J Biol

Figure 5. Col-1 expressions in cells detected by Western blot ( x
0.05; compared with model group, #P < 0.05.

± s , n = 5). Compared with normal group, *P <

Figure 6. TGF-β1, p-Smad2, and p-Smad7 protein expressions in cells detected by Western blot ( x
Compared with normal group, *P < 0.05; compared with model group, #P < 0.05.

works mainly in the form of local hormones through two
different types of receptors, i.e. B1 receptor and B2 receptor
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± s , n = 5).

(autocrine and paracrine pathways). B1 receptor is rarely
expressed in normal tissues or healthy animals. Instead, it
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is mainly expressed during stimulation and inflammation
by bacterial lipopolysaccharides and interleukins, which
may be related to inflammatory response. B2 receptor,
which exists in normal organisms with a high density, is
sensitive to BK. It is generally accepted that B2 receptor
mediates most cardiovascular effects of kinin, electrolyte
metabolism, and organ protection (Koçer et al., 2018;
Nokkari et al., 2018). Renal interstitial fibrosis (RIF) is
the common pathological basis for the development of
many progressive kidney diseases into organ failure.
However, the pathogenic mechanism has not been fully
clarified. Excessive accumulation of collagen fibers caused
by the abnormal proliferation of glomerular mesangial
cells is the main pathological change of RIF (Hsieh et al.,
2018). Therefore, finding effective means to suppress the
abnormal proliferation of glomerular mesangial cells is of
great clinical significance.
As a small glycoprotein, BK is an effector peptide of
the kallikrein-kinin system, which is widely distributed in
the kidney, salivary gland, pancreas, sweat gland, central
nervous system, and other tissues. It is mainly used for
the clinical treatment of acute ischemia-reperfusion
myocardial infarction (Zhu et al., 2019). Besides, BK can
also protect various organs in the process of fibrosis (Acuña
et al., 2018). Cui et al. (2017) reported that BK played a
notable protective role in the organ fibrosis of aging rats.
Fahmy et al. (2019) found that increasing BK intake in a
short term evidently alleviated liver fibrosis in rats with
bile congestion. Moreover, Deres et al. (2019) found
that BK obviously protected spontaneously hypertensive
rats from myocardial and vascular fibrosis. However,
the antifibrotic role of BK has never been applied to the
treatment of RIF hitherto. Herein, TGF-β1 stimulated the
proliferation of rat glomerular mesangial cells, HBZY-1,
whereas BK obviously inhibited cell proliferation, blocked
the cell cycle in G1 phase, facilitated apoptosis, and
reduced the expression of Col-1. The above results provide
a new approach for the application of BK in the antifibrotic
treatment of chronic renal diseases.
The TGF-β1/Smad signaling pathway has attracted
widespread attention in studies on renal fibrosis. TGF-β1
is one of the most crucial factors for renal fibrosis. High
expression of TGF-β1 is the central link of RIF formation,
especially in hyperplastic glomerular mesangial cells
(Cheng et al., 2019). Shi et al. (2018) verified that
TGF-β1 stimulation was able to markedly facilitate the
proliferation and fibrotic transformation of human
glomerular mesangial cells in vitro. Smad proteins play a

vital role in the formation of extracellular matrix in RIF.
Smad2, a receptor protein of TGF-β1, can transfer signals
to the nucleus to initiate the expression of collagen genes.
Smad7 is an antagonist protein of serine/threonine kinase,
which prevents the phosphorylation of activated Smad2.
Kim et al. (2008) found that the TGF-β-Smad pathway was
involved in the BK-stimulated α-SMA expression in human
adipose tissue-derived mesenchymal stem cells. Wang et al.
(2014) reported that inhibiting TGF-β1/Smad prevented
human mesangial cells from proliferation triggered by
platelet-derived growth factor-BB. Additionally, Ma et
al. (2018) verified that repressing the TGF-β1/Smad
signaling pathway relieved renal fibrosis in rats. Wei et
al. (2018) reported that BK affected TGF‑β1‑induced
epithelial‑mesenchymal transition by upregulating the
expression of Smad7 and downregulating that of pSmad3
in the TGF‑β/Smad pathway, probably as an effective
therapy for proliferative vitreoretinopathy. Furthermore,
Zhang et al. (2019) demonstrated that suppressing the
expression of Smad2 remarkably promoted high glucoseinduced fibrosis of human renal tubular epithelial cells.
In this study, after rat glomerular mesangial cells,
HBZY-1, were stimulated by TGF-β1, the number of
mitotic cells in the model group increased significantly,
the proliferation rate rose remarkably, the apoptosis
rate notably declined, and the expression of Col-1 was
markedly raised. BK and inhibitor groups had significantly
reduced cell proliferation rate and elevated apoptosis
rate. Moreover, Western blotting showed that the protein
expressions of TGF-β1 and p-Smad2 dramatically
declined, but the protein expression of p-Smad7 obviously
rose in BK group and inhibitor group. Therefore, BK may
suppress the proliferation of rat glomerular mesangial cells
and promote apoptosis by modulating the TGF-β1/Smad
signaling pathway.
5. Conclusion
In summary, BK regulates the proliferation, apoptosis, and
cycle of glomerular mesangial cells and other physiological
processes by suppressing the TGF-β1/Smad signaling
pathway. Further studies regarding whether BK modulates
the proliferation and apoptosis of glomerular mesangial
cells via pathways other than TGF-β1/Smad are ongoing
in our group.
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